Kalos Therapeutics Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • 2ndary - Private

Kalos Therapeutics General Information

Description

Developer of atrial natriuretic peptides designed to help in the treatment of cancer in patients. The company's peptides develop a safe nontoxic therapeutic that has the potential to inhibit the growth of rapidly dividing human cancer cells and put them into a sustained non-dividing state, enabling patients to receive a new class of drugs to treat cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 2550 West Union Hills Drive
  • Suite 350
  • Phoenix, AZ 85027
  • United States
+1 (858)
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 2550 West Union Hills Drive
  • Suite 350
  • Phoenix, AZ 85027
  • United States
+1 (858)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kalos Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Secondary Transaction - Private 01-May-2024 Completed Generating Revenue
2. Later Stage VC (Series B) 01-May-2016 Completed Generating Revenue
1. Later Stage VC (Series A) 01-Nov-2015 $1.27M $1.27M Completed Generating Revenue
To view Kalos Therapeutics’s complete valuation and funding history, request access »

Kalos Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A
To view Kalos Therapeutics’s complete cap table history, request access »

Kalos Therapeutics Patents

Kalos Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-2853204-A1 Methods and uses of anp (atrial natriuretic peptide), bnp (brain natriuretic peptide) and cnp (c-type natriuretic peptide)-related peptides and derivatives thereof for treatment of retinal disorders and diseases Inactive 16-Dec-2011
EP-2790714-A2 Methods and uses of anp (atrial natriuretic peptide), bnp (brain natriuretic peptide) and cnp (c-type natriuretic peptide)-related peptides and derivatives thereof for treatment of retinal disorders and diseases Inactive 16-Dec-2011
JP-2018024674-A Methods and uses of anp (atrial natriuretic peptide), bnp (brain natriuretic peptide) and cnp (c-type natriuretic peptide)-related peptides and derivatives thereof for treatment of retinal disorders and diseases Pending 16-Dec-2011
US-20150045301-A1 Methods and uses of anp (atrial natriuretic peptide), bnp (brain natriuretic peptide) and cnp (c-type natriuretic peptide)-related peptides and derivatives thereof for treatment of retinal disorders and diseases Inactive 16-Dec-2011
EP-2790714-A4 Methods and uses of anp (atrial natriuretic peptide), bnp (brain natriuretic peptide) and cnp (c-type natriuretic peptide)-related peptides and derivatives thereof for treatment of retinal disorders and diseases Inactive 16-Dec-2011 A61K38/2242
To view Kalos Therapeutics’s complete patent history, request access »

Kalos Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Kalos Therapeutics FAQs

  • When was Kalos Therapeutics founded?

    Kalos Therapeutics was founded in 2005.

  • Where is Kalos Therapeutics headquartered?

    Kalos Therapeutics is headquartered in Phoenix, AZ.

  • What is the size of Kalos Therapeutics?

    Kalos Therapeutics has 2 total employees.

  • What industry is Kalos Therapeutics in?

    Kalos Therapeutics’s primary industry is Biotechnology.

  • Is Kalos Therapeutics a private or public company?

    Kalos Therapeutics is a Private company.

  • What is Kalos Therapeutics’s current revenue?

    The current revenue for Kalos Therapeutics is .

  • How much funding has Kalos Therapeutics raised over time?

    Kalos Therapeutics has raised $1.62M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »